Newcastle Physical Therapy, Inc. | |
215 Taylor Road Newcastle CA 95658-0059 | |
(916) 663-2300 | |
(916) 663-2330 |
Full Name | Newcastle Physical Therapy, Inc. |
---|---|
Speciality | Clinic/center |
Location | 215 Taylor Road, Newcastle, California |
Authorized Official Name and Position | Chuck Spina (PESIDENT CEO) |
Authorized Official Contact | 9166632300 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Newcastle Physical Therapy, Inc. Po Box 59 215 Taylor Road Newcastle CA 95658-0059 Ph: (916) 663-2300 | Newcastle Physical Therapy, Inc. 215 Taylor Road Newcastle CA 95658-0059 Ph: (916) 663-2300 |
NPI Number | 1578645073 |
---|---|
Provider Enumeration Date | 10/20/2006 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1578645073 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261Q00000X | Clinic/center | CA15431 (California) | Primary |
News Archive
A small cadre of lawyers, some from out of state, are using New York City's age and architectural quirkiness as the foundation for a flood of lawsuits citing violations of the Americans With Disabilities Act. The lawyers are generally not acting on existing complaints from people with disabilities.
The perceived role of God in illness and recovery is a primary influence upon the health care beliefs and behaviors of American Muslims, a first-of-its-kind study has discovered. Outreach and education efforts by the health care community can help address Muslim concerns and improve health care quality in this rapidly growing population, the report recommends.
Organogenesis Inc., a commercial leader in the field of regenerative medicine, presented new data generated in collaboration with a team of expert economists from Analysis Group (a leading health economics consultancy) demonstrating the significant healthcare resource and economic burden that diabetic foot ulcers and venous leg ulcers place upon the US healthcare system.
Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.
Complete Genomics announced today that it has raised $39 million in its Series E funding round. New investor Sands Capital led this round of financing and was joined by existing investors Essex Woodlands, OVP Venture Partners, Prospect Venture Partners, OrbiMed Advisors, Highland Capital and Enterprise Partners.
› Verified 3 days ago